Editorial: Biochemical and genetic tools to investigate the underlying mechanisms and treatment of sensorimotor pathologies

Front Mol Neurosci. 2022 Oct 10:15:1041458. doi: 10.3389/fnmol.2022.1041458. eCollection 2022.

Thomas Haynes Hutson¹, Arnau Hervera^{2

3

4

5}

¹ Center for Neuroprosthetics and Brain Mind Institute, Swiss Federal Institute of Technology Lausanne, Lausanne, Switzerland.
² Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia, Barcelona, Spain.
³ Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain.
⁴ Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, Madrid, Spain.
⁵ Institute of Neuroscience, University of Barcelona, Barcelona, Spain.

No abstract available

Keywords: biochemical engineering; neurotrauma and neurodegenerative disease; optogenetics and DREADDs; sensorimotor; spinal cord injury (SCI).

Publication types